TAFA4/FAM19A4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-59651
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptides corresponding to FAM19A4 (family with sequence similarity 19 (chemokine (C-C motif)-like), member A4) The peptide sequence was selected from the middle region of FAM19A4)(50ug). Peptide sequence SSQHLRGHAGHHQIKQGTCEVVAVHRCCNKNRIEERSQTVKCSCFPGQVA The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for TAFA4/FAM19A4 Antibody
Western Blot: TAFA4/FAM19A4 Antibody [NBP1-59651]
Western Blot: FAM19A4 Antibody [NBP1-59651] - Titration: 0.2-1 ug/ml, Positive Control: U937 cell lysate.Applications for TAFA4/FAM19A4 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TAFA4/FAM19A4
Long Name
Family with Sequence Similarity 19, Member A4
Alternate Names
FAM19A4
Gene Symbol
TAFA4
UniProt
Additional TAFA4/FAM19A4 Products
Product Documents for TAFA4/FAM19A4 Antibody
Product Specific Notices for TAFA4/FAM19A4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...